Rare Cancer Research Foundation

Ppoi (formerly h37) is on a mission to create exceptional outcomes for individuals facing advanced Cancer by pushing the boundaries of science, Research, and clinical innovations. Working in deep partnership with a small group of clients with advanced cancers, ppoi explores the detailed molecular and clinical characteristics of individual client's disease to help them and their clinical team make more data-informed decisions about their treatment journey. We have already seen the success of this program in the first personalized vaccine validated with mass spectrometry in the country as well as daily wins as we work to navigate through this complex and ever-changing landscape on behalf of these patients.

A program initiated in 2023 to develop a unified platform to host combined molecular and clinical Rare Cancer data which will be shared broadly with the Cancer Research community.

Pattern.org is a groundbreaking platform that allows rcrf to work directly with Cancer patients across the country to identify patients eligible to donate tissue to Research, educate those patients on Research opportunities, consent them into such Research programs, and then coordinate the bio-logistics of moving their tissue from their local hospitals to world-class Research institutions. Pattern.org was launched with great success in 2016, and in 2023, delivered high quality, viable, living Rare Cancer tissue from both academic and community hospitals across the u.s. to critical,innovative Research initiatives.